Among the commercially available PD-L1 antibodies, SP263 antibody showed PD-L1 positivity in lung cancer equivalent to 22C3 or 28−8 antibodies, whereas SP142 antibody was reported to have the lowest PD-L1 positivity [45–47]. Here, CD274 is linked to lung cancer.